PCMOSM PDA Technical Report No. 54: Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations provides detailed guidance for the application and implementation of quality risk management (QRM) principles throughout the product lifecycle. Intended to align with ICH Q9 and present information that can be helpful to the reader on how to implement QRM, the report emphasizes QRM application during commercial manufacturing and integrating QRM into the pharmaceutical quality system.
Original price was: $325.00.$162.00Current price is: $162.00.
Technical Report No. 54 (TR 54) Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations
Parenteral Drug Association , 03/01/2012
Pages: 61
Related products
-
PDA TR 39
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 42
Original price was: $100.00.$50.00Current price is: $50.00. -
PDA TR 22
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 46
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 26
Original price was: $325.00.$162.00Current price is: $162.00.